Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples